Allarity Therapeutics, Inc. (ALLR) vs Dare Bioscience, Inc. (DARE)
A side-by-side comparison of Allarity Therapeutics, Inc. and Dare Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLR
Allarity Therapeutics, Inc.
$1.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
DARE
Dare Bioscience, Inc.
$0.84HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALLR vs DARE
growth of $100 · dividends reinvested · last 5yALLR -100.0% (-95.9%/yr)DARE -96.2% (-47.9%/yr)DARE compounded faster over this window
Log scale — wide-divergence pair
ALLR DARE
ALLR vs DARE: by the numbers
- •ALLR is the larger company ($16M vs $13M market cap).
- •Both run net losses; DARE's is the smaller (-804.37% vs -3575.07% net margin).
Metrics side by side
Valuation
| Metric | ALLR | DARE |
|---|---|---|
| P/S ratio | 46.12 | 9.25 |
| P/B ratio | 4.50 | N/A |
Profitability
| Metric | ALLR | DARE |
|---|---|---|
| Gross margin | 107.54% | -137.55% |
| Operating margin | -3939.06% | -1315.51% |
| Net margin | -3575.07% | -804.37% |
| ROE | -348.81% | N/A |
| ROIC | -41.81% | -203.50% |
Growth (annualized)
| Metric | ALLR | DARE |
|---|---|---|
| Total return CAGR (5Y) | N/A | -46.35% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.